Yahoo
HKSE HKD

Immunotech Biopharm Ltd (6978.HK)

0.360 +0.005 (+1.41%)
At close: October 30 at 4:08:06 PM GMT+8
Chart Range Bar
Loading chart for 6978.HK
  • Previous Close 0.355
  • Open 0.360
  • Bid 0.355 x --
  • Ask 0.360 x --
  • Day's Range 0.360 - 0.360
  • 52 Week Range 0.330 - 3.720
  • Volume 42,000
  • Avg. Volume 99,903
  • Market Cap (intraday) 222.3M
  • Beta (5Y Monthly) 0.09
  • PE Ratio (TTM) --
  • EPS (TTM) -0.340
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People's Republic of China. The company's core product is EAL, a multi-target cellular immunotherapy product that has completed Phase III clinical trials for the prevention of postsurgical recurrence of liver cancer. It also develops CAR-T-19 injection product for B-cell acute lymphoblastic leukaemia that is in Phase II/III clinical trial; 6B11-OCIK injection that is in Phase I clinical trial for ovarian cancer; RC19D2 for relapsed and refractory diffuse large B-cell lymphoma that is in Phase I clinical trial; and TCR-T cell series products to treat solid tumors. In addition, the company develops pre-clinical products, such as aT19 to treat hematologic malignancies; YT003 and YT008 for post transplantation infections; YT007 for solid tumors; and VAC-aT19 for hematologic malignancies. Immunotech Biopharm Ltd was founded in 2006 and is headquartered in Beijing, the People's Republic of China.

www.eaal.net

189

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

6978.HK
87.71%
HANG SENG INDEX (^HSI)
9.11%

1-Year Return

6978.HK
88.20%
HANG SENG INDEX (^HSI)
11.37%

3-Year Return

6978.HK
91.11%
HANG SENG INDEX (^HSI)
33.83%

5-Year Return

6978.HK
97.78%
HANG SENG INDEX (^HSI)
8.21%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -20.57%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -171.55M

  • Diluted EPS (ttm)

    -0.340

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    61.75M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -128.8M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: